Abcellera Biologics shares owned by Stansberry Asset Management
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Stansberry Asset Management
from 13F filings
Historical chart of Stansberry Asset Management investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Stansberry Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Stansberry Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $517k | 113k | 4.60 |
| 2023-06-30 | $663k | 103k | 6.46 |
| 2023-03-31 | $766k | 102k | 7.54 |
| 2022-12-31 | $1.0M | 100k | 10.13 |
| 2022-09-30 | $971k | 98k | 9.89 |
| 2022-06-30 | $1.1M | 101k | 10.65 |
| 2022-03-31 | $1.0M | 103k | 9.75 |
| 2021-12-31 | $1.4M | 96k | 14.29 |
| 2021-09-30 | $781k | 39k | 20.04 |
More positions owned by Stansberry Asset Management
View all positions for Stansberry Asset Management